IFNG and visceral leishmaniasis: Cystatin cured experimental visceral leishmaniasis by switching the differentiation of Th2 cells to Th1 type, as well as upregulating NO (41); cystatin and IFN-γ inhibited the growth of amastigotes in macrophages (41)